avatar
Oscar Rivera05/30/2020 15:00

Tuesday June 2, FDA is set to rule on $VYNE Therapeutics Inc 's FMX103, as a treatment option for moderate-to-severe papulopustular rosacea.

Like
3
Risk Warning: All information and statistics provided on Webull website is for reference only. It does not represent an investment recommendation to stock, options and other investment products trading.
avatar
Share your ideas here…

All Comments

avatar
asc***com·05/30/2020 16:41

from what I see the FDA actually approved it yesterday afternoon already.

Like
avatar
Oscar Rivera·05/30/2020 15:31

pdufa date

Like
avatar
Luis Calderon·05/30/2020 15:09

That was approved friday morning

Like
Oscar Rivera
0
Following
5064
Post
0
Wefolios

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.

Copyright © 2021 Webull Technologies Limited All Rights Reserved